David Serwitz

David Serwitz supports the Centers for Disease Control and Prevention’s Office of Acquisition Services in executing mission-critical procurement activities that enable public health infrastructure and scientific response capabilities. While his formal title is not listed, his work centers on facilitating acquisitions for laboratory diagnostics, biomedical research support, and facility-related services essential to CDC’s disease surveillance and outbreak response missions. He manages a diverse portfolio of contracts aligned with federal procurement regulations, ensuring timely delivery of goods and services that underpin national health security operations, including diagnostic testing systems, data analytics platforms, and laboratory facility upgrades. His contracting patterns reflect a strong preference for open competition, with over 93% of procurements issued as non-set-aside actions, indicating a focus on broad market access and technical capability over socioeconomic targeting. When small business set-asides are utilized, they are primarily structured as Total Small Business Set-Asides under FAR 19.5, demonstrating a measured but deliberate commitment to fostering competition among qualified small firms without prioritizing specific socioeconomic categories such as 8(a), HUBZone, or SDVOSB. Serwitz’s procurement focus is concentrated in key NAICS categories including Commercial and Institutional Building Construction, Medical Laboratories, and Information Services, reflecting the agency’s need for physical infrastructure, diagnostic testing capacity, and data management systems. He routinely engages vendors capable of delivering complex, compliance-heavy solutions such as CLIA-certified lab equipment, biosafety-level facility modifications, and public health informatics platforms. His expertise lies in bridging technical requirements with acquisition strategy to support CDC’s operational readiness in infectious disease control and epidemiological research.